![logo](/logos/9265.T.webp)
Yamashita Health Care Holdings,Inc.
TSE:9265.T
2615 (JPY) • At close September 6, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) JPY.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 61,555 | 58,195 | 55,145.83 | 70,131.078 | 64,658.509 | 61,533.254 | 58,692.788 | 52,517.963 | 51,615.298 | 50,310 | 51,049 | 47,132 |
Cost of Revenue
| 53,254 | 50,147 | 47,421.402 | 62,620.495 | 57,853.142 | 55,027.808 | 52,380.446 | 46,936.747 | 45,814.794 | 44,476 | 44,844 | 41,532 |
Gross Profit
| 8,301 | 8,048 | 7,724.428 | 7,510.583 | 6,805.367 | 6,505.446 | 6,312.342 | 5,581.216 | 5,800.504 | 5,834 | 6,205 | 5,600 |
Gross Profit Ratio
| 0.135 | 0.138 | 0.14 | 0.107 | 0.105 | 0.106 | 0.108 | 0.106 | 0.112 | 0.116 | 0.122 | 0.119 |
Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
General & Administrative Expenses
| 1,120 | 934 | 921.251 | 862.075 | 834.508 | 794.008 | 810.995 | 5,131 | 4,968 | 4,953 | 5,029 | 4,760 |
Selling & Marketing Expenses
| 344 | 329 | 310 | 294 | 285 | 271 | 292 | 263 | 248 | 220 | 191 | 170 |
SG&A
| 7,333 | 934 | 921.251 | 862.075 | 834.508 | 794.008 | 810.995 | 5,394.567 | 5,215.756 | 5,173 | 5,220 | 4,930 |
Other Expenses
| 55 | 50 | 57.66 | 52.563 | 64.525 | 70.085 | 58.945 | 0 | 0 | 0 | 0 | 0 |
Operating Expenses
| 7,333 | 6,886 | 6,793.666 | 6,541.735 | 6,244.835 | 5,983.124 | 5,939.043 | 5,394.567 | 5,215.756 | 5,211 | 5,387 | 5,016 |
Operating Income
| 968 | 1,156 | 930.754 | 968.842 | 560.526 | 522.316 | 373.29 | 186.649 | 584.748 | 539 | 837 | 528 |
Operating Income Ratio
| 0.016 | 0.02 | 0.017 | 0.014 | 0.009 | 0.008 | 0.006 | 0.004 | 0.011 | 0.011 | 0.016 | 0.011 |
Total Other Income Expenses Net
| -97 | -521 | 96 | 82 | 80 | -142 | -6.457 | -78.105 | 41.428 | 88 | -14 | 59 |
Income Before Tax
| 871 | 635 | 1,025.514 | 1,051.55 | 642.328 | 382.005 | 366.841 | 108.544 | 626.176 | 627 | 823 | 587 |
Income Before Tax Ratio
| 0.014 | 0.011 | 0.019 | 0.015 | 0.01 | 0.006 | 0.006 | 0.002 | 0.012 | 0.012 | 0.016 | 0.012 |
Income Tax Expense
| 293 | 423 | 330.023 | 373.058 | 182.626 | 237.583 | 145.77 | 87.811 | 294.029 | 268 | 270 | 266 |
Net Income
| 580 | 219 | 696 | 678.492 | 459.701 | 144.422 | 220.608 | 19.408 | 332.239 | 359 | 553 | 321 |
Net Income Ratio
| 0.009 | 0.004 | 0.013 | 0.01 | 0.007 | 0.002 | 0.004 | 0 | 0.006 | 0.007 | 0.011 | 0.007 |
EPS
| 227.83 | 85.79 | 272.67 | 265.77 | 180.07 | 56.57 | 87.04 | 7.75 | 131.46 | 140.67 | 216.68 | 125.78 |
EPS Diluted
| 227.83 | 85.79 | 272.67 | 265.77 | 180.07 | 56.57 | 87.04 | 7.75 | 131.46 | 140.67 | 216.68 | 125.78 |
EBITDA
| 1,181 | 1,412 | 1,229.458 | 1,230.272 | 838.865 | 831.916 | 672.202 | 352.852 | 712.996 | 678 | 1,004 | 692 |
EBITDA Ratio
| 0.019 | 0.024 | 0.022 | 0.018 | 0.013 | 0.014 | 0.011 | 0.007 | 0.014 | 0.013 | 0.02 | 0.015 |